Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Post Surgical Neuropathic Pain: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Post Surgical Neuropathic Pain: 1 US clinical trial tracked, none currently recruiting.

Post Surgical Neuropathic Pain is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Averitas Pharma, running 1 of these trials.

Enrollment posture brief

Registry condition post-surgical-neuropathic-pain

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Post Surgical Neuropathi (th…0%
Open-enrollment share among volume-matched conditions near Post Surgical Neuropathic Pain

Post Surgical Neuropathic Pain has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Post Surgical Neuropathic Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Post Surgical Neuropathic Pain is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Averitas Pharma 1 trials

Named interventions

Most-linked intervention names on Post Surgical Neuropathic Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

capsaicin 0.04% topical system Drug
1 trials
Qutenza (capsaicin) 8% topical system Drug
1 trials

US sites by state

Facility locations filed on Post Surgical Neuropathic Pain trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
North Carolina 1 trials
Michigan 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Post Surgical Neuropathic Pain page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Post Surgical Neuropathic Pain trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Averitas Pharma sponsors the most Post Surgical Neuropathic Pain trials on record, review their full trial history before evaluating a specific study. See Averitas Pharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Post Surgical Neuropathic Pain condition card totals 1 registered trials; most-linked intervention capsaicin 0.04% topical system; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.